White Papers

    • Date Published
    • June 2016

    NCPDP Recommendations for Dose Accumulation Monitoring in the Inpatient Setting: Acetaminophen Case Model

    This paper provides the healthcare industry, in particular the pharmacy and inpatient facility sectors, with historical and background information on the patient risks associated with hidden sources of acetaminophen and recommendations for best practices to mitigate those risks through facility management and electronic medical record systems.

    This white paper will appear in the August 1, 2016 issue of the American Journal of Health-System Pharmacy (AJHP). Click here to access the ahead-of-print version of the white paper

    • Date Published
    • June 2015

    NCPDP Recommendations for Improving Prescription Drug Monitoring Programs, Version 2

    This white paper examines the shortfalls of today’s prescription drug monitoring programs intended to reduce fraud and abuse and proposes a new roadmap for PDMP. The recommendations leverage best practices and NCPDP’s existing, widely adopted standards to help states standardize PDMP’s and provide real-time reporting and access to data, giving providers information in a timely manner, across state lines and across pharmacies.

    • Date Published
    • March 2014

    NCPDP Recommendations and Guidance for Standardizing the Dosing Designations on Prescription Container Labels of Oral Liquid Medications

    This paper provides the healthcare industry, in particular the pharmacy sector, with historical and background information on the patient risks associated with the dosing of liquid medications and recommendations to mitigate those risks through best practices in prescription orders, prescription labeling and the provision of dosing devices. Click here to download the resource document, a companion piece to the white paper.

1 2 3 4

For problems with the site please contact us at webmaster@ncpdp.org